It is found that hepatitis B virus can be integrated with normal liver cells in vivo, human K cells can kill liver cells when resisting and killing the virus, and the patient's immunity is weakened, which leads to the delay of the disease. Molecular biological detection technology found that hepatitis B virus can also infect some tissues outside the human liver and replicate in the corresponding tissues and cells, and the DNA of the virus can also be integrated into the cells of the tissues outside the liver.
The data show that 90% of patients with liver cancer develop into liver cancer through hepatitis to cirrhosis, 10% of hepatitis B virus may directly cause liver cancer, and about 80% of patients with liver cancer can be found to be positive for hepatitis B "three antibodies" (e antigen, e antibody and core antibody). 26% people in the high incidence area of liver cancer may be hepatitis B patients or long-term hepatitis B virus carriers. It can be seen that hepatitis, liver cirrhosis and liver cancer are closely related.
Therefore, patients with hepatitis B must receive timely and effective treatment, so as to eliminate the virus in the body, regulate the immune function, and avoid prolonging the course of disease and developing into cirrhosis and liver cancer.
Western medicines commonly used in clinic to resist hepatitis B virus, such as interferon and cytarabine, are expensive and have many adverse reactions, which are repeated after stopping taking drugs. At present, western medicine has no specific treatment for this disease, and people have high hopes for Chinese medicine.
Chinese medicine classifies hepatitis B as "jaundice" and "hypochondriac pain". According to the etiology and pathogenesis, it can be divided into five types: damp-heat and blood stasis, liver depression and spleen deficiency, liver-kidney yin deficiency, spleen-kidney yang deficiency and blood stasis blocking collaterals.
Practice has proved that Chinese medicine has a unique effect on hepatitis B for thousands of years. Some Chinese medicines, such as rhubarb, Bupleurum, Scutellaria baicalensis, Cortex Phellodendri, Rhizoma Coptidis, Huangqiao, Rhizoma Osmundae, Eupatorium odoratum, Radix Salviae Miltiorrhizae, Radix Curcumae, Radix Paeoniae Rubra, Zhang Hu, Poria, Fructus Schisandrae Chinensis, Herba Artemisiae Scopariae, and Herba Hedyotidis Diffusae, have the functions of inhibiting hepatitis B virus (HBV) and enhancing human immune function. The advantages of traditional Chinese medicine can be used to control the replication of hepatitis B virus, improve liver function, prevent further fibrosis and control and treat some precancerous lesions.